Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: JOHN WHITE who wrote (978)	6/6/1998 12:25:00 PM
From: JOHN WHITE	Read Replies (1) \| Respond to of 4650

Some of the announcement possibilities coming next week: (1) Negotiations completed with a leading cytopathology lab to test Biomoda's proprietary sputum diagnostic technology. ( What this would mean is that Biomoda's progress is on track as planned ) (2) ADOT announces licensing agreement of technology to an outside source. ( This would generate cash and later cash flow needed to enlarge production capabilities of ADOT's Electronic SLM BillBoards ) (3) ADOT announces a deal with Literal Corp. in which it has acquired the much needed hi-tech data transmission and compression patents. (Possibly explaining why the ADOT outstanding share increase of this last quarter was as large as it was )